Meta-analysis of cholesteryl ester transfer protein TaqIB polymorphism and risk of myocardial infarction

Medicine (United States)

Volumn 93, Issue 26, 2014, Pages

  Cao, Min ^a   Zhou, Zhi Wen ^b   Fang, Bang Jiang ^a   Zhao, Cheng Gen ^a   Zhou, Duan ^a  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b Shanghai Sixth People's Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL ESTER TRANSFER PROTEIN; CETP PROTEIN, HUMAN;

ARTICLE; ASIAN; BIBLIOGRAPHIC DATABASE; CARDIOVASCULAR RISK; DNA POLYMORPHISM; DOMINANT GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC RISK; GENOTYPE; HEART INFARCTION; HEART PROTECTION; HUMAN; META ANALYSIS; QUANTITATIVE ANALYSIS; RECESSIVE GENE; SENSITIVITY ANALYSIS; GENETIC POLYMORPHISM; GENETICS;

CHOLESTEROL ESTER TRANSFER PROTEINS; GENOTYPE; HUMANS; MYOCARDIAL INFARCTION; POLYMORPHISM, GENETIC;

EID: 84917709038     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000000160     Document Type: Article

References (40)

1. Kessler T, Erdmann J, Schunkert H. Genetics of coronary artery disease and myocardial infarction-2013. Current cardiology reports. 2013;15:368.
2. Lusis AJ, Mar R, Pajukanta P. Genetics of atherosclerosis. Annual review of genomics and human genetics. 2004;5:189-218.
3. Murabito JM, Pencina MJ, Nam BH, et al. Sibling cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults. J Am Med Assoc. 2005;294:3117-3123.
4. Hara M, Sakata Y, Sato H. [Genetic factors in myocardial infarction]. Rinsho Byori. 2013;61:176-183.
5. Luo JQ, Wen JG, Zhou HH, et al. Endothelial nitric oxide synthase gene G894T polymorphism and myocardial infarction: a meta-analysis of 34 studies involving 21068 subjects. PloS One. 2014;9:e87196.
6. Szpakowicz A, Pepinski W, Waszkiewicz E, et al. Polymorphism of 9p21.3 locus is associated with 5-year survival in high-risk patients with myocardial infarction. PloS One. 2013;8:e72333.
7. Zemel PC, Sowers JR. Relation between lipids and atherosclerosis: epidemiologic evidence and clinical implications. Am J Cardiol. 1990;66:7I-12I.
8. Bruce C, Tall AR. Cholesteryl ester transfer proteins, reverse cholesterol transport, and atherosclerosis. Curr Opin Lipidol. 1995;6:306-311.
9. Fielding CJ, Havel RJ. Cholesteryl ester transfer protein: friend or foe? J Clin Invest. 1996;97:2687-2688.
10. Chen SN, Cilingiroglu M, Todd J, et al. Candidate genetic analysis of plasma high-density lipoprotein-cholesterol and severity of coronary atherosclerosis. BMC Med Genet. 2009;10:111.
11. Ordovas JM. Genetic polymorphisms and activity of cholesterol ester transfer protein (CETP): should we be measuring them? Clin Chem Lab Med. 2000;38:945-949.
12. Gammon CS, Minihane AM, Kruger R, et al. TaqIB polymorphism in the cholesteryl ester transfer protein (CETP) gene influences lipid responses to the consumption of kiwifruit in hypercholesterolaemic men. Brit J Nutr. 2014;111(6):1077-1084.
13. Lu Y, Tayebi N, Li H, et al. Association of CETP Taq1B and -629C A polymorphisms with coronary artery disease and lipid levels in the multi-ethnic Singaporean population. Lipids Health Dis. 2013;12:85.
14. Tsai MY, Johnson C, Kao WH, et al. Cholesteryl ester transfer protein genetic polymorphisms, HDL cholesterol, and subclinical cardiovascular disease in the Multi-Ethnic Study of Atherosclerosis. Atherosclerosis. 2008;200:359-367.
15. Boekholdt SM, Sacks FM, Jukema JW, et al. Cholesteryl ester transfer protein TaqIB variant, high-density lipoprotein cholesterol levels, cardiovascular risk, and efficacy of pravastatin treatment: individual patient meta-analysis of 13,677 subjects. Circulation. 2005;111:278-287.
16. Thompson A, Di Angelantonio E, Sarwar N, et al. Association of cholesteryl ester transfer protein genotypes with CETP mass and activity, lipid levels, and coronary risk. J Am Med Assoc. 2008;299:2777-2788.
17. Li YY, Wu XY, Xu J, et al. Apo A5-1131T/C, FgB -455G/A, -148C/T, and CETP TaqIB gene polymorphisms and coronary artery disease in the Chinese population: a meta-analysis of 15,055 subjects. Mol Biol RepV 40. 2013:1997-2014.
18. Tenkanen H, Koshinen P, Kontula K, et al. Polymorphisms of the gene encoding cholesterol ester transfer protein and serum lipoprotein levels in subjects with and without coronary heart disease. Hum Genet. 1991;87:574-578.
19. Fumeron F, Betoulle D, Luc G, et al. Alcohol intake modulates the effect of a polymorphism of the cholesteryl ester transfer protein gene on plasma high density lipoprotein and the risk of myocardial infarction. J Clin Invest. 1995;96:1664-1671.
20. Arca M, Montali A, Ombres D, et al. Lack of association of the common TaqIB polymorphism in the cholesteryl ester transfer protein gene with angiographically assessed coronary atherosclerosis. Clin Genet. 2001;60:374-380.
21. Eiriksdottir G, Bolla MK, Thorsson B, et al. The -629CA polymorphism in the CETP gene does not explain the association of TaqIB polymorphism with risk and age of myocardial infarction in Icelandic men. Atherosclerosis. 2001;159:187-192.
22. Wu JH, Lee YT, Hsu HC, et al. Influence of CETP gene variation on plasma lipid levels and coronary heart disease: a survey in Taiwan. Atherosclerosis. 2001;159:451-458.
23. Liu S, Schmitz C, Stampfer MJ, et al. A prospective study of TaqIB polymorphism in the gene coding for cholesteryl ester transfer protein and risk of myocardial infarction in middle-aged men. Atherosclerosis. 2002;161:469-474.
24. Freeman DJ, Samani NJ, Wilson V, et al. A polymorphism of the cholesteryl ester transfer protein gene predicts cardiovascular events in non-smokers in the West of Scotland Coronary Prevention Study. Eur Heart J. 2003;24:1833-1842.
25. Keavney B, Palmer A, Parish S, et al. Lipid-related genes and myocardial infarction in 4685 cases and 3460 controls: discrepancies between genotype, blood lipid concentrations, and coronary disease risk. Int J Epidemiol. 2004;33:1002-1013.
26. Yilmaz H, Isbir T, Agachan B, et al. Effects of cholesterol ester transfer protein Taq1B gene polymorphism on serum lipoprotein levels in Turkish coronary artery disease patients. Cell Biochem Funct. 2005;23:23-28.
27. Dedoussis GV, Panagiotakos DB, Louizou E, et al. Cholesteryl ester-transfer protein (CETP) polymorphism and the association of acute coronary syndromes by obesity status in Greek subjects: the CARDIO2000-GENE study. Hum Hered. 2007;63:155-161.
28. Morgan TM, Krumholz HM, Lifton RP, et al. Nonvalidation of reported genetic risk factors for acute coronary syndrome in a largescale replication study. J Am Med Assoc. 2007;297:1551-1561.
29. Meiner V, Friedlander Y, Milo H, et al. Cholesteryl ester transfer protein (CETP) genetic variation and early onset of non-fatal myocardial infarction. Ann Hum Genet. 2008; 72 (Pt 6): 732-741.
30. Poduri A, Khullar M, Bahl A, et al. A combination of proatherogenic single-nucleotide polymorphisms is associated with increased risk of coronary artery disease and myocardial infarction in Asian Indians. DNA Cell Biol. 2009;28:451-460.
31. Wang Q, Zhou SB, Wang LJ, et al. Seven functional polymorphisms in the CETP gene and myocardial infarction risk: a meta-analysis and meta-regression. PloS One. 2014;9:e88118.
32. Andersen CJ, Blesso CN, Lee J, et al. Egg consumption modulates HDL lipid composition and increases the cholesterol-accepting capacity of serum in metabolic syndrome. Lipids. 2013;48:557-567.
33. Voight BF, Peloso GM, Orho-Melander M, et al. Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study. Lancet. 2012;380:572-580.
34. Alssema M, El-Harchaoui K, Schindhelm RK, et al. Fasting cholesteryl ester transfer protein concentration is independently associated with the postprandial decrease in high-density lipoprotein cholesterol concentration after fat-rich meals: the Hoorn prandial study. Metabolism. 2010;59:854-860.
35. Heilbronn LK, Noakes M, Clifton PM. Association between HDLcholesterol and the Taq1B polymorphism in the cholesterol ester transfer protein gene in obese women. Atherosclerosis. 2002;162:419-424.
36. Drayna D, Lawn R. Multiple RFLPs at the human cholesteryl ester transfer protein (CETP) locus. Nucleic Acids Res. 1987;15:4698.
37. Brousseau ME, OConnor JJ Jr, Ordovas JM, et al. Cholesteryl ester transfer protein TaqI B2B2 genotype is associated with higher HDL cholesterol levels and lower risk of coronary heart disease end points in men with HDL deficiency: Veterans Affairs HDL Cholesterol Intervention Trial. Arterioscler Thromb Vasc Biol. 2002;22:1148-1154.
38. Ordovas JM, Cupples LA, Corella D, et al. Association of cholesteryl ester transfer protein-TaqIB polymorphism with variations in lipoprotein subclasses and coronary heart disease risk: the Framingham study. Arterioscler Thromb Vasc Biol. 2000;20:1323-1329.
39. Freeman DJ, Griffin BA, Holmes AP, et al. Regulation of plasma HDL cholesterol and subfraction distribution by genetic and environmental factors. Associations between the TaqI B RFLP in the CETP gene and smoking and obesity. Arterioscler Thromb. 1994;14:336-344.
40. Hannuksela ML, Liinamaa MJ, Kesaniemi YA, et al. Relation of polymorphisms in the cholesteryl ester transfer protein gene to transfer protein activity and plasma lipoprotein levels in alcohol drinkers. Atherosclerosis. 1994;110:35-44.